Immunosuppressive Treatment Can Alter Visual Performance in the Royal College of Surgeons Rat

Ann E Cooper1, Jang-Hyeon Cho2, Steven Menges2

  • 11 William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis , Davis, California.

Abstract

Insights

Immunosuppression in Royal College of Surgeons (RCS) rats impairs visual function and test performance. This impacts data interpretation in translational studies using this common animal model.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Immunosuppression is vital for xenograft survival in translational research.
  • Potential side effects of immunosuppressive regimens are often overlooked.
  • The Royal College of Surgeons (RCS) rat is a model for retinal degeneration.

Purpose of the Study:

  • To evaluate the impact of immunosuppression on visual function in RCS rats.
  • To assess functional changes in immunosuppressed RCS rats compared to controls.
  • To understand implications for translational research using RCS rats.

Main Methods:

  • RCS rats and Long Evans controls were used.
  • Animals received either no treatment or systemic immunosuppression (cyclosporine A and dexamethasone).
  • Functional evaluation included optomotor response testing and electroretinography (ERG) from P45 to P180.

Main Results:

  • Immunosuppressed RCS rats showed poorer functional test performance before P90.
  • Lower spatial acuities and reduced ERG b-wave amplitudes were observed.
  • Retinal imaging and histology confirmed progressive retinal degeneration.

Conclusions:

  • Standard immunosuppression regimens (cyclosporine A plus dexamethasone) cause systemic side effects in RCS rats.
  • These side effects depress behavioral and electrophysiological test scores.
  • Findings necessitate careful consideration when interpreting data from immunosuppressed RCS rat models.

Related Concept Videos